首页> 美国卫生研究院文献>Frontiers in Immunology >Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies

【2h】

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies

机译：在减少的B细胞恶性肿瘤中加入Rituximab对B细胞恶性肿瘤的调节方案不影响移植结果：EBMT注册表分析对B细胞恶性肿瘤的同种异体干细胞移植后分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Frontiers in Immunology
作者
Agnieszka Tomaszewska; Madan Jagasia; Eric Beohou; Steffie van der Werf; Didier Blaise; Edward Kanfer; Noel Milpied; Péter Reményi; Fabio Ciceri; Jean H. Bourhis; Patrice Chevallier; Carlos Solano; Gerard Socié; Benedetto Bruno; Alessandro Rambaldi; Luca Castagna; Nicolaus Kröger; Paolo Corradini; Boris Afanasyev; Marco Ladetto; Dietger Niederwieser; Christof Scheid; Henrik Sengeloev; Frank Kroschinsky; Ibrahim Yakoub-Agha; Helene Schoemans; Christian Koenecke; Olaf Penack; Zinaida Perić; Hildegard Greinix; Rafael F. Duarte; Grzegorz W. Basak;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 7
原文格式 PDF
正文语种
中图分类免疫学;
关键词

机译：移植;B细胞恶性肿瘤;调节;Rituximab;造血细胞移植后的非复发死亡率;移植物与宿主病;

相似文献

外文文献
中文文献
专利

1. Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies [J] . Kennedy Vanessa E., Savani Bipin N., Greer John P., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第10期

机译：同种异体干细胞移植治疗B细胞恶性肿瘤后，与氟达拉滨和环丁砜相比，氟达拉滨，环磷酰胺和利妥昔单抗降低强度的调节与改善的结果相关
2. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT) [J] . M Aoudjhane, M Labopin, N C Gorin, Leukemia . 2005,第12期

机译：HLA相同兄弟姐妹同种异体造血干细胞移植患者50岁以上急性骨髓小细胞白血病患者降低强度和清髓疗法的比较结果：欧洲血液和血液研究小组急性白血病工作组（ALWP）的回顾性调查骨髓移植（EBMT）
3. Comparison of Unrelated Cord Blood and Peripheral Blood Stem Cell Transplantation in Adults with Myelodysplastic Syndrome after Reduced-Intensity Conditioning Regimen: A Collaborative Study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party [J] . Robin Marie, Ruggeri Annalisa, Labopin Myriam, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第3期

机译：降低强度条件疗法后成年骨髓增生异常综合症无关联脐带血和外周血干细胞移植的比较：Eurocord（EBMT细胞治疗和免疫生物学工作委员会血液委员会）与慢性恶性肿瘤工作组的合作研究
4. Fludarabine Phosphete and Melphalan - An Immunosuppressive Reduced Intensity Conditioning (RIC) Regimen for AUogeneic Stem Cell Transplantation in Patients with a Range of Hematological Malignancies [C] . G. Jackson, C. Richardson, G. Morgan, European Haematology Association . 2002

机译：Fludarabine phospete和Melphalan - 一种免疫抑制性降低的强度调理（RIC）治疗患者血液学恶性肿瘤患者的促孕酮干细胞移植方案
5. Pre-Transplant Risk Factors Associated With Worse Outcomes in Adolescents and Young Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [D] . Friend, Brian. 2018

机译：与经历同种异体造血干细胞移植的青少年和青少年较差的预移植危险因素
6. Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen for elderly patients (60 years and older) with hematologic malignancies using unrelated donors: a retrospective study from the French society for stem cell transplantation (SFGM-TC) [O] . Jean El Cheikh, Patrick Sfumato, Mohamad Sobh, 2016

机译：使用无关供体的老年恶性血液病患者（60岁及以上）在降低强度条件后进行同种异体造血干细胞移植：法国社会对干细胞移植的回顾性研究（SFGM-TC）
7. T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusions. [O] . D'Sa, S, Peggs, K, Pizzey, A, 2003

机译：多发性骨髓瘤患者接受T细胞耗竭，强度降低的异基因干细胞移植，并使用含alemtuzumab的调理方案，然后逐步供体淋巴细胞输注，其T细胞和B细胞免疫重建及临床结局。

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies

著录项

相似文献

相关主题

期刊订阅